StockData
Palisade Bio, Inc. logo

Palisade Bio, Inc. (PALI) stock

PALINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$0.94−0.07 (-6.72%)

Close on Nov 18, 2026Market cap $164.18MP/E –Yield –

Palisade Bio price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Palisade Bio's price to sales ratio was 406.2× on Nov 11, 2026, against 41.3× a year earlier. Over the last 3 years it ranged from 14.8× to 468.7×, with a median of 90.0×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 2026406.2×+391.3
2024Apr 30, 202414.9×−6.8
2023Dec 29, 202321.7×−24.5
2019Jul 31, 201946.2×−9.8
2018Dec 31, 201856.0×−410.7
2012Oct 31, 2012466.7×–

More Palisade Bio figures

See a number that looks wrong?